The Promise and Reality of NGTs

Watch and Listen to 2022’s Summer Special episode

Our Transformation Talks Summer Special is here!

Next Generation Therapies (NGTs) currently in development will deliver treatments that address the underlying cause of diseases, disrupt the biopharmaceutical environment, and offer a life-long solution to patients. They create unprecedented opportunities for patients and will be measurable in lives saved, disabilities reduced, and overall quality of life improvements. However, along with these benefits come unprecedented challenges for insurance coverage, reimbursement, and payment.

Tune in to learn about risks and challenges in developing NGTs, bringing them to the market, and how NGTs can change patients’ lives once their value is understood and correctly attributed by the decision makers / payers.

This special episode is not only be available in audio format but also in video and features a stellar group of guests:

  • Andrea Mantovani – Vice President, Global Market Access and Pricing, Alira Health
  • Oswald Bentinck – Vice President – Head of Market Access EMEA, Novartis Gene Therapies
  • Pietro Sternini – Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies
Watch the episode “The Promise and Reality of NGTs”:

Listen to the episode:

The episode “The Promise and Reality of Next Generation Therapies” is also available on the following platforms:

Google Podcasts      Spotify

Multimedia
Category:
Published on:
July 20, 2022
Meet our speakers:
Andrea Mantovani headshot

Andrea Mantovani

Vice President, Global Market Access and Pricing, Alira Health
Oswald Bentinck headshot

Oswald Bentinck

Vice President - Head of Market Access EMEA, Novartis Gene Therapies
Pietro Sternini headshot

Pietro Sternini

Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies
Meet our host:
Kenny Carberry

Kenny Carberry

Director, Clinical Development, Alira Health

Related news

Multimedia July 20, 2022
The Promise and Reality of NGTs
Listen to the episode “The Promise and Reality of Next Generation Therapies".
Market Access
Events June 30, 2022
DTx France 2022
We are pleased to announce that we will be joining as speakers and exhibitors at DTx France 2022. This hybrid event will focus on the latest DTx trends, regulatory framework, market(...)
DTx trends Market Access Regulatory
Multimedia June 21, 2022
Increasing Access to Genomic Testing in Europe
Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics”.
Genomic Testing Market Access MedTech
Multimedia May 10, 2022
VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development
Join the 2nd episode of VacciTalks where together with vaccine expert Roberto Camerini we will peek behind the scenes of vaccine development and get an insider look at the difficulties,(...)
Market Access
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Multimedia April 28, 2022
Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe
Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Clinical Market Access RWE
Publications April 20, 2022
White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective
In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.
Market Access
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.